Rapid Dose Therapeutics Corp. (CSE:DOSE)
Canada
· Delayed Price · Currency is CAD 0.2000
-0.0100 (-4.76%)
Jun 30, 2025, 9:30 AM EDT
Rapid Dose Therapeutics Revenue
In the fiscal year ending February 28, 2025, Rapid Dose Therapeutics had annual revenue of 2.09M CAD with 104.34% growth. Rapid Dose Therapeutics had revenue of 668.58K in the quarter ending February 28, 2025, with 247.04% growth.
Revenue
2.09M
Revenue Growth
+104.34%
P/S Ratio
13.28
Revenue / Employee
n/a
Employees
n/a
Market Cap
27.70M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sienna Senior Living | 896.45M |
| Green Thumb Industries | 1.64B |
| dentalcorp Holdings | 1.58B |
| Extendicare | 1.47B |
| WELL Health Technologies | 990.34M |
| Cronos Group | 179.08M |
| Trulieve Cannabis | 1.71B |
| Curaleaf Holdings | 1.89B |